Covaxin

Photo: India Blooms

Only Covaxin Gives 65.2% Efficacy Against COVID-19 Delta Variant: Lancet

The recent study by the Lancet peer-review said Covaxin surpassed all the vaccines in terms of efficacy against the Delta variant by providing 65.2% efficacy, said vaccine maker Bharat Biotech on November 12. The Lancet also said that it provides 77.8% efficiency against symptomatic patients. It provides ''70.8% protection against all variants of SARS-CoV-2 virus,'' said the maker. However, 12% of people experienced common side effects of the… read-more

Fri, 12 Nov 2021 - 03:42 PM / by Brijesh Goswami

Tags: Covid-19, Covaxin, Lancet, Bharat Bitotech, Study

Courtesy: Time Now News

Covaxin

Photo: The Financial Express

Bharat Biotech's Covaxin Gets Guyana's Approval, Awaits WHO's Recognition

Guyana on November 2 announced that it has decided to add Bharat Biotech's Covaxin to its recognised list of COVID-19 vaccines. Notably, Australia also announced to recognise Covaxin as COVID-19 vaccine in its country on November 1. However, the company is still waiting for World Health Organisation's approval for Covaxin which will help it to get recognition from all the countries in the world. 

Tue, 02 Nov 2021 - 05:55 PM / by Brijesh Goswami

Tags: Guyana, Covaxin, Bharat Bitotech, Covid-19, India

Courtesy: ANI